Cardiovascular System — The Risk You Are Not Being Told About

Estrogen protects blood vessels — it promotes nitric oxide production (keeping arteries flexible), maintains favorable cholesterol ratios (higher HDL, lower LDL), reduces inflammation, and supports healthy vascular lining. After menopause, this protection disappears. LDL cholesterol rises by an average of 10 to 15 percent in the 2 years surrounding menopause. Blood pressure increases. Arterial stiffness accelerates. The risk of heart attack doubles within 10 years of menopause.

Heart disease is the number one killer of women — far exceeding breast cancer — yet women's cardiovascular risk is systematically under-recognized and undertreated. A study in the Journal of the American Heart Association found that women were less likely than men to receive statin therapy, blood pressure treatment, and lifestyle counseling despite equivalent or higher risk. Menopause should be a trigger for comprehensive cardiovascular risk assessment.

Bones — The Silent Collapse

Estrogen suppresses osteoclasts (bone-destroying cells). When estrogen drops, osteoclast activity surges and bone is broken down faster than it can be rebuilt. Women lose 2 to 3 percent of bone density per year in the first 5 to 7 years after menopause. A study in the Archives of Internal Medicine found that 50 percent of women over 50 will have an osteoporosis-related fracture during their remaining lifetime.

What to do: Get a DEXA scan at age 65 (or earlier if you have risk factors). Ensure 1,200mg calcium and 800-2,000 IU vitamin D daily. Weight-bearing exercise and resistance training are essential — they directly stimulate bone formation. If DEXA shows osteoporosis, medications (bisphosphonates, denosumab) reduce fracture risk by 50 to 70 percent.

Brain — Cognitive Changes and Alzheimer's Risk

Estrogen supports brain blood flow, synaptic plasticity, and neurotransmitter production. During perimenopause, many women experience brain fog, word-finding difficulty, and memory lapses. A study in Neurology found that cognitive complaints during the menopausal transition are objectively measurable — not imagined. The good news: most cognitive changes during perimenopause stabilize after menopause.

However, long-term Alzheimer's risk is significantly higher in women than men — roughly two-thirds of Alzheimer's patients are female. Estrogen withdrawal is increasingly recognized as a contributing factor, through its effects on amyloid clearance, tau pathology, and neuroinflammation. Sleep, exercise, cardiovascular risk management, and social engagement are the strongest modifiable protective factors.

Metabolism, Weight, and Muscle

Estrogen influences fat distribution — premenopausal women store fat subcutaneously (hips and thighs), while postmenopausal women accumulate visceral fat (abdomen). This redistribution is metabolically harmful — visceral fat produces inflammatory cytokines, drives insulin resistance, and increases cardiovascular and cancer risk. Many women gain 5 to 8 percent of body weight during the menopausal transition, even without dietary changes.

Muscle mass declines 3 to 8 percent per decade after age 30 and accelerates after menopause. Protein requirements increase — postmenopausal women need 1.2 to 1.5 grams per kilogram daily (more than the RDA). Resistance training at least twice weekly is the most effective intervention for both muscle preservation and metabolic health.

Genitourinary Syndrome — The Symptom Nobody Discusses

Estrogen maintains the vaginal lining, urethral tissue, and pelvic floor. After menopause, these tissues thin, dry, and lose elasticity. Symptoms include vaginal dryness, painful intercourse (dyspareunia), recurrent urinary tract infections, urinary urgency, and incontinence. Collectively called genitourinary syndrome of menopause (GSM), it affects up to 50 percent of postmenopausal women according to a study in Menopause.

Unlike hot flashes (which typically improve over time), GSM progressively worsens without treatment. Vaginal estrogen (cream, ring, or tablet) is the most effective treatment — it restores tissue health locally with minimal systemic absorption. A study in the New England Journal of Medicine found that vaginal estrogen reduced UTI recurrence by 50 percent. Over-the-counter vaginal moisturizers and lubricants provide symptomatic relief. Pelvic floor physical therapy addresses incontinence.

What You Can Do — An Evidence-Based Menopause Strategy

Hormone replacement therapy (HRT): When started within 10 years of menopause or before age 60, HRT reduces hot flashes by 75 percent, protects bone density, reduces cardiovascular risk, and improves quality of life. The Women's Health Initiative, when re-analyzed by age of initiation, found that HRT started in the first decade of menopause was associated with reduced mortality. HRT is not for everyone — discuss your individual risk profile (breast cancer history, clotting history) with your doctor.

Exercise: 150 minutes of moderate aerobic activity plus 2 sessions of resistance training weekly. This combination addresses cardiovascular risk, bone density, muscle mass, metabolism, sleep, and mood simultaneously. Diet: Mediterranean pattern, adequate protein (1.2-1.5g/kg), calcium, vitamin D, and omega-3 fatty acids.

Screening: Cardiovascular risk assessment including lipids, blood pressure, and fasting glucose. DEXA scan for bone density. Mammogram. Colorectal cancer screening. Thyroid function (thyroid disease increases after menopause). Mental health screening — depression and anxiety rates peak during the menopausal transition.

Menopause is not a disease. It is a biological transition. But it is a transition that requires proactive health management to prevent the accelerated cardiovascular, bone, brain, and metabolic decline that unaddressed estrogen withdrawal causes. The women who do best in midlife and beyond are the ones who treat this transition as a medical event that deserves medical attention — not something to simply endure.